AGI-6780, 98%, 100mg
$399.00
In stock
SKU
Q809
AGI-6780 inhibits the tumor-associated mutant IDH2/R140Q. Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. Inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.
THIS PRODUCT IS NOT FOR HUMAN USE
This Product Is For Research Use Only
Cat#: Q809
Name: AGI-6780
CAS#: 1432660-47-3
Chemical Formula: C21H18F3N3O3S2
Molecular Weight: 481.51
Appearance:White to off-white solid powder
Purity:>98%
Delivery within 3-7 Days
For Bulk quantities,
Write Your Own Review